Medscape February 20, 2025
In the final days of 2024, three pharmaceutical giants sued the federal government. In their joint lawsuit, Amgen, Eli Lilly and Company, and UCB claim several Nevada STD clinics were unlawfully qualified for the federal drug discount program, 340B, giving them access to millions of dollars in drugmaker discounts for which they weren’t eligible.
The legal action is just the latest in a series of recent lawsuits by drugmakers targeting the 340B program, which gives qualified hospitals a 20%-50% discount on certain outpatient drugs.
In November, both Johnson & Johnson and Eli Lilly and Company filed their own lawsuits against the US Department of Health and Human Services (HHS) after the regulator rejected their plans to change how they offer...
Today's Sponsors
Today's Sponsor